China SXT Pharmaceuticals-ASXTC
13F holders, Q2 2024 (June 30)7holders +3
3new positions
0sold out
1famous investor
$1.09avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding China SXT Pharmaceuticals-A (SXTC) in their 13F filings, up 3 from Q1 2024. 3 opened new positions and 0 sold out. The largest holders were Virtu Financial LLC ($34K), Citadel Advisors ($17K) and UBS Group AG ($14K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- China SXT Pharmaceuticals-A
- CUSIP
- G2161P140
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $64K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 70,489 shares bought, net +70,489 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Virtu Financial LLC | 0.00% | New | 31,607 | $34K |
| Citadel Advisors | 0.00% | New | 16,115 | $17K |
| UBS Group AG | 0.00% | Add +157087.5% | 12,575 | $14K |
| Bank of Montreal | 0.00% | New | 10,000 | $13K |
| Acadian Asset Management LLC | 0.00% | No change | 2,759 | $2K |
| Qube Research & Technologies Ltd | 0.00% | Add +194.2% | 303 | $327 |
| Banque Cantonale Vaudoise | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is SXTC's weight in each manager's 13F, not the share of China SXT Pharmaceuticals-A the manager owns.